Stock Research: Divi's Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Divi's Laboratories

NSI:DIVISLAB INE361B01024
19
  • Value
    10
  • Growth
    81
  • Safety
    Safety
    99
  • Combined
    37
  • Sentiment
    62
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Divi's Laboratories Limited is an India-based company engaged in pharmaceutical ingredients, intermediates, and nutraceutical ingredients with a focus on exports and custom synthesis. Its main businesses include manufacturing active pharmaceutical ingredients (APIs) and intermediates, and providing contract manufacturing services for global innovator companies across various therapeutic areas. The company operates in India and has subsidiaries in the USA and Europe. In the last fiscal year, the company had a market cap of $21095 million, profits of $587 million, revenue of $1095 million, and 18300 employees.

more

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock Divi's Laboratories are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Divi's Laboratories. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 81% of competitors in the same industry. The consolidated Safety Rank at 99 means that the company has a financing structure that is safer than 99% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 62, which means that professional investors are more optimistic about the stock than for 62% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 10, meaning that the share price of Divi's Laboratories is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 90% of alternative stocks in the same industry. ...read more

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 5 11 15
Growth
81 81 43 81
Safety
Safety
99 99 100 100
Sentiment
62 67 49 6
360° View
360° View
19 19 59 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
29 7 1 27
Opinions Change
50 94 50 17
Pro Holdings
n/a 81 73 40
Market Pulse
84 60 64 55
Sentiment
62 67 49 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 5 11 15
Growth
81 81 43 81
Safety Safety
99 99 100 100
Combined
37 37 55 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
1 1 5 3
Price vs. Earnings (P/E)
10 5 12 22
Price vs. Book (P/B)
10 14 28 20
Dividend Yield
49 31 39 44
Value
10 5 11 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
67 84 74 76
Profit Growth
77 74 34 63
Capital Growth
78 14 50 70
Stock Returns
53 99 37 65
Growth
81 81 43 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
93 100 96 100
Refinancing
32 42 50 40
Liquidity
93 100 98 100
Safety Safety
99 99 100 100

Similar Stocks

Discover high‑ranked alternatives to Divi's Laboratories and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Infosys

NSI:INFY
Country: India
Industry: IT Consulting & oth. Services
Size: XX-Large
Full Stock Analysis

CESC

NSI:CESC
Country: India
Industry: Electric Utilities
Size: Medium
Full Stock Analysis

Mphasis

NSI:MPHASIS
Country: India
Industry: IT Consulting & oth. Services
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: